Soluble fragments of influenza virus PB2 protein capable of binding RNAcap

Details for Australian Patent Application No. 2008309939 (hide)

Owner European Molecular Biology Laboratory (EMBL)

Inventors Tarendeau, Franck; Cusack, Stephen; Guilligay, Delphine; Hart, Darren

Agent Spruson & Ferguson

Pub. Number AU-A-2008309939

PCT Pub. Number WO2009/046983

Priority 60/998,398 09.10.07 US; 61/070,792 25.03.08 US; 61/123,456 08.04.08 US

Filing date 9 October 2008

Wipo publication date 16 April 2009

International Classifications

C07K 14/11 (2006.01) Peptides having more than 20 amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

C07K 14/16 (2006.01) Peptides having more than 20 amino acids

C12Q 1/18 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - Testing for antimicrobial activity of a material

Event Publications

20 May 2010 PCT application entered the National Phase

  PCT publication WO2009/046983 Priority application(s): WO2009/046983

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008309940-HIV preventive vaccine based on HIV specific antibodies

2008309934-Protein expression from multiple nucleic acids